Best Telehealth Clinics in Oklahoma (2026)

Oklahoma's telehealth statutes are codified at 59 O.S. § 478.1 (physician-patient relationship via telemedicine) and Title 36 §§ 6802-6803 (insurance coverage). The state has a specific prohibition on using telehealth to establish a physician-patient relationship for prescribing opiates, synthetic or semisynthetic opiates, benzodiazepines, or carisoprodol. This ban is explicit and does not have a sunset date.

The opiate/benzo prohibition is narrow. Testosterone (Schedule III anabolic steroid) is not an opiate or benzodiazepine and is not affected by this restriction. GLP-1 medications are not controlled substances and are unaffected. ED, hair loss, and HRT medications are also unaffected. The prohibition targets specific drug classes, not all controlled substances.

For non-prohibited controlled substances like testosterone, Oklahoma permits telehealth prescribing without a mandatory in-person visit. The standard of care is the same as for in-person encounters. Insurers cannot restrict telehealth prescribing beyond what applicable state and federal law requires.

Payment parity is required under Title 36 §§ 6802-6803. Insurers must reimburse telehealth services on the same basis and at least the same rate as in-person services.

Oklahoma is an active IMLC member. Out-of-state physicians can obtain expedited Oklahoma licensure through the compact.

HB 2298 (effective November 1, 2025) expanded APRN practice authority significantly. Eligible APRNs can now apply for independent prescriptive authority, making Oklahoma effectively a full practice authority state for experienced NPs. This is a recent change that expands the pool of telehealth providers who can prescribe controlled substances in Oklahoma.

Audio-only telephone, email, text, instant messaging, non-secure video, and fax are excluded from Oklahoma's telehealth definition. Video is the required modality for initial consultations involving controlled substance prescribing.

Oklahoma has 4.0 million residents. Provider availability is good, supported by IMLC membership and the absence of an in-person requirement for non-opiate controlled substances. The recent NP practice authority expansion further improves access.

All major TRT providers serve Oklahoma. Maximus ($100/mo, all 50 states), Hone Health ($25/mo, all 50 states), TRT Nation ($99/mo, 45 states including OK), BraverX ($129/mo), PeterMD ($99/mo), DudeMeds ($77/mo), and Titan Medical ($99/mo) are available. Enhance MD also serves Oklahoma.

GLP-1 availability is unrestricted. Embody, SkinnyRx, DirectMeds, Zealthy, Remedy Meds, GobyMeds, Sesame Care, MEDVi, Shed, Sunlight, and Mochi Health all serve Oklahoma. Oklahoma Medicaid (SoonerCare) does not cover GLP-1s for obesity.

All HRT, hair loss, and ED providers with national coverage serve Oklahoma. Midi Health accepts insurance. No known state-specific provider exclusions for OK.

TRT pricing from available providers: DudeMeds $77/mo ($1,124/year), TRT Nation $99/mo ($1,446/year), PeterMD $99/mo ($1,188/year), Maximus $100/mo ($1,300/year), BraverX $129/mo ($1,548/year), Defy Medical $200/mo ($2,800/year).

GLP-1 ranges from $99/mo to $399/mo. Median is $179/mo. SoonerCare (Oklahoma Medicaid) does not cover GLP-1s for obesity. Patients must pay out of pocket or use commercial insurance.

Oklahoma does not tax prescription medications. The state sales tax is 4.5% (plus local taxes) but Rx drugs are exempt. Oklahoma has a top marginal income tax rate of 4.5% (reduced from 4.75% effective January 1, 2026 under HB 2764).

HRT: Midi Health (insurance), PlushCare ($20/mo), Evernow ($35/mo). ED: Hims $17/mo to MEDVi $119/mo.

Oklahoma has a low cost of living compared to the national average. Telehealth pricing is national and does not vary by state.

TRT (testosterone replacement therapy)

Oklahoma does not require an in-person visit for TRT prescribing via telehealth. The opiate/benzo telehealth prohibition (59 O.S. § 478.1) does not apply to testosterone. The federal DEA waiver through December 2026 applies. APRN independent prescriptive authority under HB 2298 expands provider options. Both compounded and FDA-approved testosterone are available.

GLP-1 weight loss

No state-specific GLP-1 restrictions in Oklahoma. Federal FDA compounding rules apply. SoonerCare does not cover GLP-1s for obesity. Commercial insurance coverage varies by plan.

HRT (hormone replacement therapy)

HRT follows standard federal prescribing rules in Oklahoma. No additional state restrictions apply.

Hair loss

Hair loss treatment follows standard federal prescribing rules in Oklahoma. No additional state restrictions apply.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules in Oklahoma. No additional state restrictions apply.

Peptides

Peptide therapy follows standard federal rules in Oklahoma. Non-controlled peptides have fewer restrictions. Controlled peptides that are not opiates or benzodiazepines can be prescribed via telehealth.